image
Lantheus Holdings, Inc. LNTH
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
Watchlist
$ 76.83
-4.96 %
$ 5.34 B
Market Cap
12.76
P/E
BALANCE SHEET
1.65 B ASSETS
24.97%
Growth Rates
1Year 24.97%
3Years 23.82%
5Years 30.29%
7Years 30.52%
10Years 20.24%
835 M LIABILITIES
-4.44%
Growth Rates
1Year -4.44%
3Years 32.93%
5Years 17.76%
7Years 12.67%
10Years 5.33%
816 M EQUITY
82.47%
Growth Rates
1Year 82.47%
3Years 16.64%
5Years 62.96%
7Years 38.26%
10Years 18.51%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Lantheus Holdings, Inc.
image
Current Assets 1.09 B
Cash & Short-Term Investments 714 M
Receivables 284 M
Other Current Assets 87.9 M
Non-Current Assets 565 M
Long-Term Investments 0
PP&E 192 M
Other Non-Current Assets 373 M
Current Liabilities 187 M
Accounts Payable 41.2 M
Short-Term Debt 823 K
Other Current Liabilities 145 M
Non-Current Liabilities 648 M
Long-Term Debt 616 M
Other Non-Current Liabilities 31.8 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
ASSETS
Cash & Cash Equivalents 713.7 415.7 98.5 79.6 92.9 113.4 76.3 51.2 28.6 19.7 18.6 33.3
Short Term Investments 0 0 0 0 0 0 0 0 0 0 0 0
Receivables 284.3 213.4 89.3 54.0 43.5 43.8 40.3 36.8 37.3 41.8 39.2 39.6
Inventory 64.0 35.5 35.1 35.7 29.2 33.0 26.1 17.6 15.6 15.6 18.3 18.0
Other Current Assets 23.8 26.0 22.9 14.9 7.3 5.2 5.2 5.2 8.6 4.1 3.1 5.6
Total Current Assets 1 085.8 677.6 235.8 184.2 172.9 195.4 147.8 110.8 90.1 81.2 79.2 96.5
PP&E 192.0 122.2 116.8 120.2 116.5 107.9 93.0 94.2 86.5 96.0 97.7 109.6
Intangible Assets 152.0 315.3 348.5 376.0 7.3 9.1 11.8 15.1 29.6 29.6 36.5 69.0
Goodwill 61.2 61.2 61.2 58.6 15.7 15.7 15.7 15.7 15.7 15.7 15.7 15.7
Long Term Investments 0 1.6 2.1 2.1 0 0 0 0 74 K 7.3 9.6 0
Other Long Term Assets 9.9 32.8 36.6 58.5 21.6 30.2 28.5 20.1 20.4 19.3 22.6 33.8
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 1 651.1 1 321.3 863.8 869.8 405.9 439.8 383.9 255.9 242.4 249.6 261.3 324.7
LIABILITIES
Accounts Payable 41.2 20.6 20.8 16.3 18.6 18.0 17.5 18.9 11.7 15.7 18.1 18.9
Short Term Debt 0.8 0.4 11.6 20.7 10.3 2.8 2.8 3.6 3.6 8.0 8.0 0
Other Current Liabilities 145.3 226.8 58.1 43.5 37.2 32.0 26.5 21.2 20.4 24.7 25.5 29.8
Total Current Liabilities 187.3 247.7 90.5 80.5 66.1 52.8 46.8 43.8 35.7 48.5 55.6 56.1
Long Term Debt 616.1 583.2 179.7 215.4 184.1 263.7 265.4 274.5 349.9 399.3 392.3 398.8
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0.2 12 K 0.4
Other Liabilities 31.8 43.3 129.2 59.7 41.1 52.4 48.4 44.1 42.1 33.0 35.4 36.7
Total Liabilities 835.3 874.1 399.3 355.6 291.3 368.8 360.6 362.4 427.7 488.8 496.8 497.8
EQUITY
Common Stock 0.7 0.7 0.7 0.7 0.4 0.4 0.4 0.4 0.3 51 K 51 K 50 K
Retained Earnings 133.5 (193.2) (221.2) (149.9) (136.5) (168.1) (209.0) (332.4) (359.2) (344.4) (340.9) (279.3)
Other Accumulative Comprehensive Income/Loss (1.0) (1.3) (0.5) (2.0) (1.0) (1.1) (1.0) (0.9) (2.0) (1.6) (0.4) 1.3
Total Equity 815.9 447.1 464.4 514.2 114.6 71.0 23.3 (106.5) (185.3) (239.3) (235.5) (173.1)
Total Liabilities and Equity 1 651.1 1 321.3 863.8 869.8 405.9 439.8 383.9 255.9 242.4 249.6 261.3 324.7
SHARES OUTSTANDING
Common Shares Outstanding 68.3 68.5 67.5 54.1 39.0 38.2 37.3 32.0 24.4 17.8 18.1 17.8 18.0